Acino Holding AG (XSWX:ACIN) Price-to-Owner-Earnings : (As of May. 14, 2024)

View and export this data going back to . Start your Free Trial

What is Acino Holding AG Price-to-Owner-Earnings?

As of today (2024-05-14), Acino Holding AG's share price is CHF113.60. Acino Holding AG does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for Acino Holding AG's Price-to-Owner-Earnings or its related term are showing as below:

XSWX:ACIN's Price-to-Owner-Earnings is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 28.12
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-14), Acino Holding AG's share price is CHF113.60. Acino Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2013 was CHF0.00. Therefore, Acino Holding AG's PE Ratio for today is N/A.

As of today (2024-05-14), Acino Holding AG's share price is CHF113.60. Acino Holding AG's EPS without NRI for the trailing twelve months (TTM) ended in was CHF0.00. Therefore, Acino Holding AG's PE Ratio without NRI for today is N/A.

During the past 11 years, Acino Holding AG's highest PE Ratio without NRI was 55.84. The lowest was 0.00. And the median was 21.71.

Acino Holding AG Price-to-Owner-Earnings Historical Data

The historical data trend for Acino Holding AG's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acino Holding AG Price-to-Owner-Earnings Chart

Acino Holding AG Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Price-to-Owner-Earnings

Get a 7-Day Free Trial

Acino Holding AG Semi-Annual Data
	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Price-to-Owner-Earnings	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Acino Holding AG's Price-to-Owner-Earnings

For the Drug Manufacturers - General subindustry, Acino Holding AG's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acino Holding AG's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acino Holding AG's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Acino Holding AG's Price-to-Owner-Earnings falls into.

Acino Holding AG Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Acino Holding AG's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	113.60	/	0.00
	=

Acino Holding AG (XSWX:ACIN) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

Acino Holding AG Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Acino Holding AG's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

Acino Holding AG (XSWX:ACIN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acino Holding AG (XSWX:ACIN) » Definitions » Price-to-Owner-Earnings

Traded in Other Exchanges

N/A

Address

Website

http://www.acino-pharma.com

Acino Holding AG is a Switzerland-based company engaged in the pharmaceutical industry. The Company develops, manufactures, and markets pharmaceuticals in novel drug delivery forms internationally. It is divided into four segments Business to Consumer (BtC); Business to Business (BtB); Technology marketing (TM); and Production (Prod). The BtC segment comprises all direct marketing activities. Under the company's "Acino Switzerland" brand and, with the promise of Swiss quality, the company sells its products in emerging markets around the globe. This reporting segment includes the business purchased from Mepha/Cephalon in the Middle East, Africa, Latin America and Asia. The BtB segment comprises Acino's business with its internally developed products, for which the company also owns the intellectual property rights. Acino develops and produces high-quality medicines with proven active ingredients and modern drug delivery systems and grants licenses for them to leading pharmaceutical and generic pharmaceutical companies worldwide. The technology marketing segment comprises a broad spectrum of fully integrated contract services, including procurement, contract development, production and packaging for companies in the life sciences industry. On behalf of these customers, Acino develops a comprehensive product pipeline on the basis of its special technological know-how. This includes both new types of medicines as well as projects with innovative drug delivery systems for established active ingredients. The production segment is responsible for the manufacturing of products and the supplying of the other three segments, and generates turnover through the reimbursement of its services. The manufacturing costs of products are credited to the production segment at standard prices along with remuneration in the form of a mark-up for materials and production costs.

Acino Holding AG (XSWX:ACIN) Headlines

No Headlines